Quote:

---

Whatever the case might be, once we get approved, with 600000 doses (1.2M vials) we should have a revenue of app. $1.4 Billion ($1153 per shot). In 2021 this figure should be much higher as we ramp up sales.

---

Agreed.

However, we do need to factor payments to AbbVie, Lantheus Holdings (Progenics), and of course American Regent.